Fabiano Cantarelli

ORCID: 0000-0001-7569-1246
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acute Myocardial Infarction Research
  • Coronary Interventions and Diagnostics
  • Liver Disease and Transplantation
  • Cardiac Imaging and Diagnostics
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Corporate Taxation and Avoidance
  • Venomous Animal Envenomation and Studies
  • Peripheral Artery Disease Management
  • Abdominal vascular conditions and treatments
  • Peptidase Inhibition and Analysis
  • Liver Disease Diagnosis and Treatment
  • Cardiac Fibrosis and Remodeling
  • Heart Failure Treatment and Management
  • Cardiovascular Function and Risk Factors
  • Cerebrovascular and Carotid Artery Diseases
  • Uterine Myomas and Treatments
  • Rabies epidemiology and control

Escola Superior Dom Helder Câmara
2017-2020

Universidade de Pernambuco
2019-2020

Instituto de Medicina Integral Professor Fernando Figueira
2019

Universidade Federal de Pernambuco
2003

Carbohydrate antigen 125 (CA125) is a congestion and inflammation biomarker has been proved to be related worse prognosis in heart diseases. However, the precise relationship between elevated CA125 patients with ST-segment elevation myocardial infarction (STEMI) not yet sufficiently studied. We set out determine association of all-cause mortality at 6 months STEMI. CA125, N-terminal pro brain natriuretic peptide (NTproBNP) high sensitive C-reactive protein (hs-CRP) were measured 245 admitted...

10.1038/s41598-020-67548-8 article EN cc-by Scientific Reports 2020-07-03

Carbohydrate antigen 125 (CA125) has long been used as an ovarian cancer biomarker. However, because it is not specific for cells, CA125 could also be to monitor congestion and inflammation in heart disease. Acute failure (HF) identify patients with a worse prognosis ST-segment elevation myocardial infarction (STEMI). We aimed determine the association of acute HF STEMI compare N-terminal pro brain natriuretic peptide (NTproBNP) cross-sectional study. At admission, were examined define...

10.1590/1414-431x20199124 article EN cc-by Brazilian Journal of Medical and Biological Research 2019-01-01

Introduction Cardiac events are rarely associated with ophidian accidents, especially those involving snakes of the Elapidae family. We report on a snake bite victim who, within few hours after accident, developed myocardial infarction in inferior wall good clinical evolution. […] Myocardial Infarction Snake Bite

10.5935/2359-4802.20170068 article EN cc-by International Journal of Cardiovascular Sciences 2017-01-01

OBJETIVO: Apresentar dados epidemiológicos de pacientes esquistossomóticos na forma hepatoesplênica com varizes do fundo gástrico, assim como avaliar os resultados uma estratégia cirúrgica no manuseio destas varizes. MÉTODO: No período janeiro 1992 à julho 2001 foram acompanhados Serviço Cirurgia Geral Hospital das Clínicas da Universidade Federal Pernambuco 125 submetidos esplenectomia ligadura veia gástrica esquerda (LVGE), desvascularização grande curvatura estômago e esclerose...

10.1590/s0100-69912003000100005 article PT cc-by Revista do Colégio Brasileiro de Cirurgiões 2003-02-01

OBJETIVO: Analisar pré-operatoriamente o peso do baço como fator prognóstico tratamento cirúrgico de pacientes portadores esquistossomose mansônica. MÉTODOS: Foram analisados 114 pacientes, mansônica com antecedentes hemorragia digestiva, submetidos a cirúrgico. Os foram divididos em três grupos: Grupo 1 - menor que 500 gramas (17); 2 entre e 1.000 (58); 3 acima (39). RESULTADOS: No recidiva hemorrágica foi 17,6%, trombose da veia porta 5,9% não houve mortalidade. A incidência...

10.1590/s0100-69912002000100007 article PT cc-by Revista do Colégio Brasileiro de Cirurgiões 2002-02-01

The goal of this study was to evaluate the performance InspironTM coronary stent (Scitech Medical™, Goiás, Brazil). sirolimus-eluting uses an ultrathin L-605 cobalt-chromium alloy with a 75 μm strut thickness platform coated abluminal biodegradable polymer. polymer is eliminated from body through tricarboxylic acid cycle in 6-9 months, releasing 80% drug within 30 days after its deployment.It prospective, single-center registry. To represent clinical practice, all patients undergoing...

10.1155/2020/6340716 article EN cc-by Journal of Interventional Cardiology 2020-12-17

Background Individualized use of glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention in scenarios with high thrombotic load or occurrence flow abnormalities may be considered, despite scarce scientific evidence. Our objective was to compare patients undergoing treated not the procedure. Methods A national, multicenter, retrospective study that included consecutive intervention, inhibitors, between June 2006 and March [...]

10.31160/jotci2018;26(2)a0017 article EN cc-by Journal of Transcatheter Interventions 2018-11-29

Uterine leiomyoma and coronary artery disease are two common diseases in women. However, the association of uterine bleeding caused by with unstable syndrome is not frequent. Here we describe a case patient active vaginal angina who underwent unique approach performing percutaneous procedures. The report demonstrates that new interventional options can be used to control patients need angioplasty.

10.5935/2359-4802.20190008 article EN cc-by International Journal of Cardiovascular Sciences 2019-01-01
Coming Soon ...